交易 Bristol Myers BMY

出售
 購買

BristolMyers實時圖表

5m 15m 30m 1h 4h 1d 1w

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%)： 開倉 高 低

最新新聞

Frances Wang 2025 Mar 30, 16:00

哈雷戴維森第四季度銷售暴跌：哈雷戴維森的營收下降60%

So Ze Dong 2025 Mar 25, 16:00

S&P500指數三連漲！GameStop宣布投資比特幣股價狂飆

Christine Voong 2025 Mar 21, 07:30

黃金價格走勢受美元走勢影響回落，仍穩守 3,000 美元關口

Christine Voong 2025 Mar 21, 04:40

美元指數走強至 103.81 點，美聯儲維持利率不變，市場關注貿易關稅與美元匯率走勢

Christine Voong 2025 Mar 20, 08:20

黃金價格走勢創歷史新高！現貨金觸及 3,057 美元，美聯儲降息預期與美元走勢疲弱支撐漲勢

Christine Voong 2025 Mar 20, 07:25

比特幣價格走勢上揚！美聯儲維持降息預測，加密貨幣市場風險偏好回暖

Christine Voong 2025 Mar 19, 08:00

國際原油價格走勢承壓：美國原油庫存激增，美俄停火協議影響供應預期

Christine Voong 2025 Mar 19, 07:25

國際黃金價格創歷史新高！避險需求推升，美聯儲決策影響黃金價格走勢

聯絡方式

點差

0.40

點差(%)

0.6787 %

槓桿

1:10

隔夜利息（買入）

-0.0597 %

隔夜利息（賣出）

-0.0292 %

貨幣

USD

交易時間

市場開放

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

121271689216

流通股份

2034759936

收益日期（下一個）

2001-08-07

現金殖利率 

2025-05-01

除息日

2025-04-04

遠期年股息率

2.48

遠期年現金殖利率

0.0416

每股盈餘

-4.41

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%)：

立即交易

立即交易

立即交易

立即交易
查看所有金融工具
Trustpilot